Profile
Bo Kruse served as the Chief Financial Officer at Genmab A from 2005 to 2008.
He then worked as a Senior Associate at PricewaterhouseCoopers (Denmark).
In 2009, he became the Chief Financial Officer at Azanta A, where he worked until 2015.
Currently, he holds the position of CFO, Secretary, Treasurer, and Executive VP at Y-mAbs Therapeutics, Inc. starting from 2019.
Mr. Kruse completed his undergraduate and graduate studies at Copenhagen Business School.
Former positions of Bo Kruse
| Companies | Position | End |
|---|---|---|
| YMAS THER | Director of Finance/CFO | 2024-06-27 |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Director of Finance/CFO | 2014-12-31 |
| GENMAB A/S | Director of Finance/CFO | 2008-06-01 |
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Corporate Officer/Principal | - |
Training of Bo Kruse
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Commercial Services |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs within oncology, women's healthcare, and addiction medicine | Health Technology |
Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
- Stock Market
- Insiders
- Bo Kruse
















